Montair 5mg Chewable Tablet Strawberry contains Montelukast, a medicine classified as a Leukotriene Receptor Antagonist. This medication is specifically designed to manage and prevent the symptoms associated with asthma and seasonal allergic rhinitis in children and adolescents aged between 6-14 years. It can also be effective in preventing bronchospasm triggered by physical activities like exercise.

Asthma is a chronic respiratory condition characterized by inflammation, swelling, and narrowing of the airways, leading to symptoms such as wheezing, difficulty in breathing, chest pain, and coughing. Additionally, excessive mucus production further obstructs the air passages, making it challenging for air to flow freely.

Seasonal allergic rhinitis, commonly known as hay fever, is an allergic reaction triggered by exposure to various allergens like pollen, dust, mold, or animal dander. This condition typically manifests as inflammation of the nasal lining, resulting in symptoms such as nasal congestion, frequent sneezing, and red, watery, or itchy eyes.

It is essential to note that Montair 5mg Chewable Tablet Strawberry is intended for preventive purposes and cannot provide immediate relief during an ongoing asthma attack. Therefore, it is advisable to have an inhaled rescue medication readily available in case of emergencies.

For optimal results, ensure that your child consumes Montair 5mg Chewable Tablet Strawberry regularly, following the dosage instructions prescribed by the doctor. Before initiating the medication, it is crucial to inform the healthcare provider about your child's overall health condition, existing medical conditions, and any known allergies.

Common adverse effects associated with the use of Montair 5mg Chewable Tablet Strawberry in children include stomach pain, headaches, upper respiratory tract infections, skin rashes, nausea, and vomiting. In case any of these side effects persist or become bothersome, seek guidance from your child's healthcare provider promptly.